Bridging Evidence Gaps: Complete Real-World Patient Journeys
Target RWE’s patient registries provide the most comprehensive real-world datasets, powered by advanced analytics and expert curation models
Transform Your Research with Our Real-World Registries
Target RWE's deep longitudinal and cross-sectional patient journeys support precise decision-making, driving innovation in drug development and patient care. Leverage our proven real-world registries in liver disease, gastroenterology, and dermatology for impactful research.
![item.GetValue("imageAltTag")](/media/2215/longitudinal_safety.jpg)
With Target RWE, partners can monitor patient outcomes over time to ensure the long-term safety and effectiveness of treatments. Our data captures complete patient journeys, allowing you to identify emerging safety signals and evaluate the sustained benefits of your therapies in real-world settings. This continuous monitoring supports informed decision-making and enhances patient care.
![item.GetValue("imageAltTag")](/media/2216/comparative_safety.jpg)
Target RWE’s rich data solutions enable comparative safety analyses and pharmacovigilance, helping you evaluate and compare the safety profiles of your products with other treatments. Our datasets support the identification of adverse events and drug interactions, ensuring compliance with regulatory requirements and enhancing your ability to manage product safety effectively.
![item.GetValue("imageAltTag")](/media/2217/pmr_pass.jpg)
Leverage Target RWE’s extensive data to meet FDA and EMA requirements for post-marketing surveillance and PASS studies. Our real-world evidence provides the robust support needed for prospective studies. By continuously monitoring patient outcomes, you can validate long-term safety and efficacy, address emerging safety concerns, and support label enhancements with confidence.
![item.GetValue("imageAltTag")](/media/2214/product_utilization.jpg)
Our extensive data supports the analysis of drug utilization and exploratory strategies, enabling you to uncover new opportunities for your products. By examining real-world usage patterns, you can identify trends, optimize dosing regimens, and explore potential new indications. Target RWE provides the evidence needed for informed decision-making.
![item.GetValue("imageAltTag")](/media/1368/rwe_stock_2.jpg)
Leverage Target RWE’s rich data to support new drug applications and label enhancement efforts. Our longitudinal and cross-sectional datasets provide the comprehensive evidence needed to demonstrate the safety and efficacy of your drug trials and research studies. By utilizing this real-world data, you can strengthen your regulatory submissions and achieve successful label expansions, ensuring your products reach their full potential in the market.
What Sets Our Registries Apart?
Therapeutic Areas & Disease Indications
Target RWE has longstanding experience in liver disease, gastroenterology, and immune-mediated inflammatory skin conditions (dermatology) with an expanded portfolio of 30+ disease states, including autoimmune, neurologic, metabolic disorders, and rare diseases. Our extensive registries provide robust real-world data curated from both structured and unstructured EMR, enabling deep analysis of patient cohorts and disease progression variables along the drug development life cycle.
Related Resources
PUBLICATION
Real World TARGET-NASH Analysis Shows High Concordance Between New MASLD Definitions & Prior TARGET-NASH Pragmatic Definitions
CONTENT
Target RWE Research Presented at EASL 2024: Video Presentation by Arun J. Sanyal, MBBS, MD
NEWS
World’s Largest Liver Disease-Focused Registry Surpasses 400,000 Patient Enrollment Milestone
![Registries_CTA](/media/2223/communities_cta.jpg)